Kolon Pharmaceutical, Inc.
Soonjae Cho is an accomplished pharmaceutical professional with extensive experience in marketing and management, currently serving as the Deputy General Manager at Kolon Pharmaceutical, Inc. since September 2010. In this role, Soonjae Cho has successfully developed and implemented marketing strategies, identified business opportunities through market analysis, and improved sales representatives' skills through comprehensive training. Prior to this, Soonjae Cho held multiple positions at Wyeth Pharmaceuticals, including Senior Product Manager, where responsibilities included managing marketing strategies for Rapamune and leading initiatives for the Vaccine business that established Wyeth Korea as a market leader. Early experience at Dongshin Pharmaceuticals involved developing sales policies and training programs, alongside recognition for excellence in sales performance. Soonjae Cho holds a Bachelor of Science degree in Biological Science from Ajou University.
This person is not in any teams
This person is not in any offices
Kolon Pharmaceutical, Inc.
Kolon Pharmaceutical, Inc. was established in 1958 with a mission to contribute on happiness of mankind and social welfare by enhancing people’s quality of life and providing top medical service thru development of innovative drugs with its respect for life and health. Kolon Pharmaceutical is a subsidiary of Kolon group which is one of the biggest industrial conglomerates of Korea that has core business domains in pharmaceuticals, biotechnology, cutting-edge materials, fashion, construction, environment, trade and IT. Kolon group’s health business unit is composed of three subsidiaries and they are Kolon Pharmaceuticals, Kolon Life Science(biotechnology) and Kolon Wellcare(drug store business). Kolon Pharmaceutical developed many outstanding products like Bicogreen for constipation, cold remedy Comy syrup & tablet, anti-fungal drug Konitra and Tamsulo capsule for prostatism with its own technology and also co-developed Brexin tablet(β-Cyclodextrin Prioxicam), Remicut SR capsule(Emedastine difumarate) and Pransus syrup(Pranoprofen) with outstanding pharmaceutical companies like Chiesi, Hisamitsu and Organon since its establishment. Kolon Pharmaceutical is also expanding its global presence by exporting its quality products like Flavon(Ginko biloba ext.), Diverine(Gliclazide), Tavisin(Ofloxacin), Clovana(Diclofenac) and Turant(Acetylcysteine) to Vietnam, Pakistan, Yemen and many other Middle Eastern countries. Our continuous efforts led us to fruitful outcomes in significant areas of our business especially new molecule research, joint research, development of API, new formulation and combination new drug.